Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-687-1 | CAS number: 162303-51-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The study objective was to determine the toxicokinetics fo the n-butyl alcohol parameters measured according to standard protocol but guideline followed was not mention. Read-across justification: The substance is hydrolytically unstable. When it comes in contact with water or moisture complete hydrolysis will take place with no significant reaction products other than alcohol and hydrated titanium dioxide. This rapid hydrolysis (hydrolysis half-life < 3 minutes to < 2 hours) is the driving force for the toxicokinetics of target substance. Because of the rapid hydrolysis, the influence of the mode of administration through inhalation, dermal and oral is related to the hazardous degradation product (alcohol) released from the target substance. The identification of degradation products from the hydrolysis study conducted for the target substance verifies that there are no impurities in the alcohol released from the target substance, which might change the hazardous properties of the target substance compared to the properties of the pure alcohol. As there is a mechanistic reasoning to the read-across, the unnecessary animal testing is avoided by using the read-across data from the degradation product (relevant alcohol) to evaluate irritation, sensitization and the short term and long-term toxicological effects and mutagenicity of the target substance.
Data source
Reference
- Reference Type:
- publication
- Title:
- Fate of n-Butanol in Rats after Oral Administration and Its Uptake by Dogs after Inhalation or Skin Application
- Author:
- G. D. DIVINCENZO AND M. L. HAMILTON
- Year:
- 1 978
- Bibliographic source:
- TOXICOLOGY AND APPLIED PHARMACOLQGY 48, 3 1 l-325 (1979)
Materials and methods
- Objective of study:
- absorption
- distribution
- excretion
- toxicokinetics
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 417 (Toxicokinetics)
Test material
- Reference substance name:
- Butan-1-ol
- EC Number:
- 200-751-6
- EC Name:
- Butan-1-ol
- Cas Number:
- 71-36-3
- Molecular formula:
- C4H10O
- IUPAC Name:
- 1-Butanol
- Details on test material:
- - Name of test material (as cited in study report): n-butanol
- Physical state: liquid
- Radiochemical purity (if radiolabelling): >97%
- Specific activity (if radiolabelling): 1.71 mCi/mmol
- Stability under test conditions: stable
- Storage condition of test material: stable
- Locations of the label (if radiolabelling): n-(1-14C) Butanol
Constituent 1
Constituent 2
- Radiolabelling:
- yes
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles RIver Laboratories
- Weight at study initiation: 200-250 g
- Fasting period before study: 16 hours
- Housing: Glass Delmar Roth metabolism chambers
- Individual metabolism cages: yes
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 deggres
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours night
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Radiolablelled n-(1-14C) Butanol was mixed with corn oil
- Duration and frequency of treatment / exposure:
- single dose administration
Doses / concentrations
- Remarks:
- Doses / Concentrations:
4.5, 45, 450 mg/kg of body weight
- Control animals:
- yes
- Positive control reference chemical:
- none
- Details on study design:
- - Dose selection rationale: Not reported
- Rationale for animal assignment (if not random): not reported - Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled (delete / add / specify): urine, serum or other tissues, cage washes, expired CO2
- Time and frequency of sampling: 4, 8, 24 hours
METABOLITE CHARACTERISATION STUDIES
- Tissues and body fluids sampled : urine, faeces, tissues, cage washes, bile
- Time and frequency of sampling: 4, 8, 24 hours
- Method type(s) for identification (e.g. GC-FID, GC-MS, Liquid scintillation counting, NMR, TLC)
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- concentration of n-butanol in the plasma of rats dosed with 450 mg/kg. Each point is the mean + SE for three rats. The highest concentration of n-butanol was 70.9 pg/ml at I hr. n-Butanol disappeared from the plasma rapidly and at 4 hr was below the limit of detection.
- Details on distribution in tissues:
- The tissue distribution of radioactivity in rats dosed with 450 mg/kg n-[1J4C]butanol is presented in Table 2. Values are expressed as the percentage of the dose for four rats. The highest concentrations of radioactivity were found in the liver (3.88%) and blood (0.74%) at 8 hr. The overall distribution of radioactivity in other tissues was relatively low. Pooled 24-hr urine collections from rats Dosed with 450 mg/kg were treated with 3 N hydrochloric acid or fi-glucuronidase and then extracted with diethyl ether. The extract was counted and analyzed by gas chromatography. About 75 % of the radioactivity was detected as n-butanol, presumably both as an O-sulfate (44.4%) and as an O-glucuronide (30.7 o/0). Urea accounted for the remainder of the radioactivity.
- Details on excretion:
- percentage of the total radioactivity recovered in the breath, urine, feces, and carcasses of rats dosed with it- [ 1 J4C]butanol. Radioactivity was eliminated rapidly in expired air as 14C0,. In rats dosed with 450 mg/kg over 44% of the administered dose was eliminated within 4 hr; 69.3 and 83.3 % were eliminated at 8 and 24 hr, respectively. Urinary radioactivity accounted for 4.4% of the dose at 24 hr. Fecal radioactivity was negligible at 4 and 8 hr and was less than 1.0% of the dose at 24 hr. The radioactivity remaining in the carcass was 42.2 % at 4 hr, 27.2 % at 8 hr, and 12.3 % at 24 hr. The overall recovery of 14C was 86.7 “/:, at 4 hr, 99.6% at 8 hr, and 101 % at24 hr. Unchanged n-butanol in expired air accounted for less than 1.0 % of the dose. Rats dosed with 4.5 or 45 mg/kg showed a
similar excretion pattern to that of rats dosed with 450 mg/kg.
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- Butanol was excreated in the urine appearently as an o-sulfate and as an o-glucuronid both of which accounted for 75% of the radioactivty.
Any other information on results incl. tables
Read-across justifications and data matrices are presented in IUCLID section 13.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): no bioaccumulation potential based on study results
According to this study oral administration of radiolabelled butanol dosed at 4.5, 45, 450 mg/kg. Less than 1% of the administered dose was excreated unchanged and 2.6 to 5.2 % of the dose was excreated in urine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Embora a ECHA disponibilize muito material em linha na sua língua, uma parte desta página está disponível apenas em inglês. Mais informações sobreas práticas de multilinguismo da ECHA.
Bem-vindo ao sítio Web da ECHA O navegador Internet Explorer 7 (e versões anteriores) não é totalmente suportado por este sítio Web. Por favor atualize o seu Internet Explorer para uma versão mais recente.
Este sítio Web utiliza cookies a fim de garantir a melhor experiência possível nos nossos sítios Web.
Saiba mais sobre como utilizar cookies.